Comments

GlycoMimetics Insider Trading Activity

GLYCNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
GlycoMimetics (GLYC) ForecastNewsEarningsGlycoMimetics (GLYC) OptionsGuidanceDividendsAnalyst Ratings

Insider Trades

Short Interest

GlycoMimetics Insider Trading Activity | NASDAQ:GLYC | Benzinga

Track the latest GlycoMimetics insider trading activity. Stay informed on recent buys, sells, and market impact for GlycoMimetics stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are GlycoMimetics Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

There has been no Insider buying or selling in the last 90 days.

Ownership Statistics for GlycoMimetics Inc

Shares Outstanding
64.514M
Insider Shares Owned
2.495M
Insider Percentage Owned
3.87%
Institutional Shares Held
6.111M
Institutional Percentage Held
9.47%
Aug 09, 2024Invus Public Equities LPInvus Public Equities Advisors LLCSiren LLCInvus Global Management LLCRAYMOND DEBBANE—-322.36K$0.19-$61.21KSELL-4.85%6.32MAug 07 - Aug 08View
Aug 07, 2024Invus Public Equities LPInvus Public Equities Advisors LLCSiren LLCInvus Global Management LLCRAYMOND DEBBANE—-220.25K$0.19-$41.18KSELL-3.21%6.64MAug 05 - Aug 06View
Aug 05, 2024Invus Public Equities LPInvus Public Equities Advisors LLCSiren LLCInvus Global Management LLCRAYMOND DEBBANE—-349.76K$0.20-$71.10KSELL-4.85%6.86MAug 01 - Aug 02View
Jul 30, 2024Invus Public Equities LPInvus Public Equities Advisors LLCSiren LLCInvus Global Management LLCRAYMOND DEBBANE—-1.38M$0.23-$315.26KSELL-16.06%7.21MJul 26 - Jul 30View
Jun 24, 2024Edwin RockCHIEF MEDICAL OFFICER305.00K$0.26$78.82KBUY81.25%680.40KJun 20 - Jun 21View
Jun 20, 2024Brian HahnSVP FINANCE, CFO17.50K$0.25$4.33KBUY32.93%70.64KJun 18View
Sep 25, 2023Edwin RockCHIEF MEDICAL OFFICER65.40K$1.38$90.26KBUY21.10%375.40KSep 21 - Sep 22View
May 18, 2023Brian HahnSVP FINANCE, CFO-3.70K$1.95-$7.21KSELL-6.51%53.14KMay 17View
May 11, 2023DANIEL JUNIUSDIRECTOR30.00K$1.56$46.80KBUY47.43%93.25KMay 10View
May 09, 2023Bruce JohnsonSVP & CHIEF COMMERCIAL OFFICER13.50K$1.57$21.20KBUY10.76%138.98KMay 08View
Feb 28, 2023Invus Public Equities LPArtal International SCAArtal International Management SASA Group ArtalSA WestendAmaury WittouckWestend Administratiekantoor StichtingInvus Public Equities Advisors LLC10% OWNER100.00K$1.70$170.00KBUY1.18%8.59MFeb 24View
Feb 23, 2023Invus Public Equities LPArtal International SCAArtal International Management SASA Group ArtalSA WestendAmaury WittouckWestend Administratiekantoor StichtingInvus Public Equities Advisors LLC10% OWNER400.00K$1.78$712.25KBUY4.94%8.49MFeb 21 - Feb 23View
Feb 17, 2023Invus Public Equities LPArtal International SCAArtal International Management SASA Group ArtalSA WestendAmaury WittouckWestend Administratiekantoor StichtingInvus Public Equities Advisors LLC10% OWNER1.52M$2.00$3.03MBUY23.05%8.09MFeb 15 - Feb 17View
Feb 13, 2023Invus Public Equities LPArtal International SCAArtal International Management SASA Group ArtalSA WestendAmaury WittouckWestend Administratiekantoor StichtingInvus Public Equities Advisors LLC10% OWNER11.45K$3.24$37.12KBUY0.17%6.57MFeb 09View
Jan 27, 2023SCOTT SANDELL10% OWNER-3.65M$3.14-$11.48MSELL-62.01%2.24MJan 25 - Jan 26View
Jan 06, 2023SCOTT SANDELL10% OWNER-71.36K$2.76-$196.86KSELL-1.81%3.88MJan 05View
Jan 04, 2023SCOTT SANDELL10% OWNER-398.13K$2.98-$1.19MSELL-9.23%3.91MDec 30 - Jan 04View
Dec 27, 2022Edwin RockCHIEF MEDICAL OFFICER110.00K$2.25$247.50KBUY55.00%310.00KDec 22View
Nov 18, 2022DANIEL JUNIUSDIRECTOR20.00K$1.87$37.40KBUY46.24%63.25KNov 17View
Nov 16, 2022Edwin RockCHIEF MEDICAL OFFICER200.00K$1.54$309.00KBUY∞200.00KNov 14 - Nov 15View
Nov 14, 2022TIMOTHY PEARSONDIRECTOR19.40K$1.29$25.03KBUY369.52%24.65KNov 11View
Nov 14, 2022Harout SemerjianCHIEF EXECUTIVE OFFICER25.00K$1.29$32.25KBUY∞25.00KNov 11View
Nov 14, 2022Brian HahnSVP FINANCE, CFO20.00K$1.06$21.20KBUY54.28%56.84KNov 11View
Nov 14, 2022John MagnaniSVP RESEARCH, CSO45.05K$1.17$52.70KBUY13.82%370.92KNov 11View
Nov 14, 2022Armand GirardSVP, CHIEF BUSINESS OFFICER6.50K$1.05$6.83KBUY28.68%29.16KNov 11View
Mar 10, 2022John MagnaniSVP RESEARCH, CSO-3.23K$1.09-$3.52KSELL-0.98%325.88KMar 09View
Mar 10, 2022Armand GirardSVP, CHIEF BUSINESS OFFICER-2.34K$1.09-$2.55KSELL-9.36%22.66KMar 09View
Mar 10, 2022Brian HahnSVP FINANCE, CFO-2.92K$1.09-$3.18KSELL-7.34%36.84KMar 09View
Nov 18, 2021Patricia AndrewsDIRECTOR40.00K$2.05$82.00KBUY761.90%45.25KNov 16View
Dec 30, 2020Rachel King—46.65K$2.52-$182.61KOPTION EXERCISE13.13%401.81KDec 28View
Nov 06, 2020PIL PARTNERS BVFFUND VALUE BIOTECHNOLOGYBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT—1.27M$2.60$3.29MPURCHASE∞630.45KNov 04View
Nov 03, 2020PIL PARTNERS BVFFUND VALUE BIOTECHNOLOGYBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT—932.61K$2.75$2.56MPURCHASE∞544.36KOct 30View

FAQ

Q

Is insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

People Also Watch

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved